Previous Section
Review Articles
61. Cholesterol absorption inhibitors as a therapeutic option for hypercholesterolaemia.
- Author
- Burnett JR; Huff MW;
- Institution
- Royal Perth Hospital, Department of Core Clinical Pathology & Biochemistry, PathWest Laboratory Medicine WA, Wellington Street Campus, GPO Box X2213, Perth, WA 6847, Australia. john.burnett@health.wa.gov.au
- Journal
- Expert Opin Investig Drugs. 2006 Nov;15(11):1337-51.
- Abstract URL
- Click here to view abstract
62. Cholesterol management.
- Author
- Griffith K;
- Institution
- Primary Care Cardiovascular Society, USA.
- Journal
- Practitioner. 2006 Sep;250(1686):23-4, 26, 29.
63. How safe is aggressive statin therapy?
- Author
- Guthrie RM;
- Institution
- The Ohio State University College of Medicine, Columbus, OH 43212, USA. guthrie.1@osu.edu
- Journal
- Prog Cardiovasc Nurs. 2006 Summer;21(3):140-5.
- Abstract URL
- Click here to view abstract
64. The role of high-density lipoprotein cholesterol in the prevention and possible treatment of cardiovascular diseases.
- Author
- Choi BG; Vilahur G; Yadegar D; Viles-Gonzalez JF; Badimon JJ;
- Institution
- Cardiovascular Biology Research Laboratory, Zena and Michael A. Weiner Cardiovascular Institute, Mount Sinai School of Medicine, New York, NY 10029, USA.
- Journal
- Curr Mol Med. 2006 Aug;6(5):571-87.
- Abstract URL
- Click here to view abstract
65. Update for primary healthcare providers: recent statin trials and revised National Cholesterol Education Program III guidelines.
- Author
- Hennekens CH; Hollar D; Eidelman RS; Agatston AS;
- Institution
- Miller School of Medicine, University of Miami, Miami, Florida, USA. profchhmd@prodigy.net
- Journal
- MedGenMed. 2006 Feb 23;8(1):54.
- Abstract URL
- Click here to view abstract
66. Update on lipid-lowering therapy and LDL-cholesterol targets.
- Author
- Wiviott SD; Cannon CP;
- Institution
- TIMI Study Group, Cardiovascular Division, Brigham and Women's Hospital, Department of Medicine, Harvard Medical School, Boston, MA 02115, USA. swiviott@partners.org
- Journal
- Nat Clin Pract Cardiovasc Med. 2006 Aug;3(8):424-36.
- Abstract URL
- Click here to view abstract
67. Narrative review: lack of evidence for recommended low-density lipoprotein treatment targets: a solvable problem.
- Author
- Hayward RA; Hofer TP; Vijan S;
- Institution
- Department of Veterans Affairs, VA Center for Practice Management and Outcomes Research, VA Ann Arbor Healthcare System, and University of Michigan Schools of Medicine and Public Health, Ann Arbor, Michigan 48113-0170, USA. rhayward@umich.edu
- Journal
- Ann Intern Med. 2006 Oct 3;145(7):520-30.
- Abstract URL
- Click here to view abstract
68. The safety of aggressive statin therapy: how much can low-density lipoprotein cholesterol be lowered?
- Author
- Jacobson TA;
- Institution
- Office of Health Promotion and Disease Prevention, Department of Medicine, Emory University School of Medicine, Atlanta, GA 30303, USA. tjaco02@emory.edu
- Journal
- Mayo Clin Proc. 2006 Sep;81(9):1225-31.
- Abstract URL
- Click here to view abstract
69. Niacin-ER/statin combination for the treatment of dyslipidemia: focus on low high-density lipoprotein cholesterol.
- Author
- Chrysant SG; Ibrahim M;
- Institution
- Oklahoma Cardiovascular and Hypertension Center and University of Oklahoma School of Medicine, Oklahoma City, 73132-4904, USA. schrysant@yahoo.com
- Journal
- J Clin Hypertens (Greenwich). 2006 Jul;8(7):493-9; quiz 500-1.
- Abstract URL
- Click here to view abstract
